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Disinfection of noncritical environmental surfaces and equipment is an essential component of an in-
fection prevention program. Noncritical environmental surfaces and noncritical medical equipment surfaces 
may become contaminated with infectious agents and may contribute to cross-transmission by acqui-
sition of transient hand carriage by health care personnel. Disinfection should render surfaces and equipment 
free of pathogens in sufficient numbers to prevent human disease (ie, hygienically clean).
There is excellent evidence in the scientific literature that envi-
ronmental contaminationplays an important role in the transmission
of several keyhealth care–associatedpathogens, includingmethicillin-
resistant Staphylococcus aureus (MRSA), vancomycin-resistant
Enterococcus (VRE), Acinetobacter sp, norovirus, and Clostridium
difficile.1-4 All of these pathogens have been demonstrated to persist
in the environment for days (in some casesmonths), frequently con-
taminate theenvironmental surfaces in roomsof colonizedor infected
patients, transiently colonize the hands of health care personnel, be
transmitted by health care personnel, and cause outbreaks in which
environmental transmission was deemed to play a role. Impor-
tantly, a study by Stiefel et al demonstrated that contact with the
environment was just as likely to contaminate the hands of health
care providers as was direct contact with the patient.5 Further, ad-
mission to a room inwhich the previous patient had been colonized
or infectedwithMRSA,VRE,AcinetobacterorCdifficilehasbeen shown
to be a risk factor for the newly admitted patient to develop colo-
nization or infection.6-8 The purpose of this article, which is adapted
fromotherpublications,4,9,10 is todiscuss theavailableoptions formoni-
toring environmental cleaning-disinfection and discussmethods for
improving environmental cleaning-disinfection.
IMPORTANCE OF PRODUCT AND PRACTICE
The disinfectants used in health care facilities are 1-step prod-
ucts, meaning they clean and disinfectant in 1-step rather than
requiring 2 independent steps (ie, cleaning, followed by
disinfection).10 In general, no precleaning is necessary unless a spill
or gross contamination is present, in which case cleaning pre-
cedes the use of a disinfectant. Disinfectants are intended for use
on hard, nonporous surfaces; however, some products are Environ-
mental Protection Agency (EPA)–registered for application to soft
surfaces, such as hospital privacy curtains.11 Hospitals should avoid
the use of noncleanable surfaces, such as fabric chairs, in clinical
areas and use a cleanable covering fabric (eg, vinyl). Cleaning is an
important component of the cleaning-disinfection process because
dust, dirt, and organic matter interfere with the effectiveness of the
disinfectant by altering the antimicrobial activity of the disinfec-
tant or protecting the pathogen from exposure to the disinfectant.
In this article, we use the term cleaning-disinfection to reference
this 1-step process for cleaning and disinfecting a noncritical item.10
Cleaning refers to the removal of surface debris (eg, dust, organic
material), whereas disinfection refers to the use of a disinfectant
or germicide designed to kill microorganisms. Cleaning-disinfection
or environmental cleaning, which refers broadly to an organized
process for cleaning, disinfecting, and monitoring,12,13 is a horizon-
tal control measure. Horizontal controls are broad-based approaches
to infection prevention because they attempt reduction to all in-
fections caused by all pathogens and include hand hygiene,
environmental control, and minimizing unnecessary use of inva-
sive devices.14 Often cleaning is enhanced by detergents and
surfactants. Surfactants enhance the cleaning efficacy of the
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disinfectant and ensure complete and even coverage of the surface,
preventing beading that occurs with some liquids.10,15 It is impor-
tant to achieve even and thorough coverage of a surface to result
in even and complete disinfection. Multiple studies have shown 10%-
50% of the surfaces in patient rooms colonized or infected with C
difficile, MRSA, and VRE are contaminated with these pathogens, and
a lack of thoroughness of cleaning contaminated surfaces in patient
rooms (mean 32% of objects cleaned) has been linked to an overall
120% increased risk of infection to the next occupant in that room.1,6,16
Although the process of selecting an optimal health care product
or disinfectant used for low-level disinfection of noncritical items
is commonplace in health care facilities, there are a very limited
number of articles in the peer-reviewed literature on this topic.10
The disinfectant or the product, is 1 of the 2 components essential
for effective disinfection. Table 1 identifies the characteristics of the
ideal disinfectant. Studies support the use of disinfection rather than
the use of a nongermicidal detergent on environmental surfaces in
health care.18,19 One recent study showed that daily use of a disin-
fectant applied to environmental surfaces with a 80% compliance
is superior to a nongermicidal detergent because it results in sig-
nificantly reduced rates of health care–associated infections (HAIs)
caused by C difficile, MRSA, and VRE.20 Nongermicidal detergents are
not recommended for multiple reasons,19 including detergent wipes
transfer significant amounts of epidemiologically important patho-
gens (eg, MRSA, C difficile) over surfaces21 and disinfectants are more
effective than detergents in reducingmicrobial contamination.22 Sim-
ilarly, results have demonstrated efficient transfer of C difficile spores
from contaminated-to-clean surfaces by nonsporicidal wipes and
overused sporicidal wipes.23 To date, the perfect product for health
care surface disinfection has not been introduced; however, there
is a wide array of excellent disinfectants that offer a range of char-
acteristics (Table 2).
To keep patients as safe as possible, health care facilities must
consider what pathogens are the most common causes of HAIs, the
most common causes of outbreaks andward closures, and the unique
pathogens of their facility. The product selected should be effec-
tive against the microorganisms that are the most common causes
of HAIs and outbreaks (Table 3), according to nationally reported
data. Because vegetative bacteria (eg, S aureus, Enterococcus, Es-
cherichia coli, coagulase-negative Staphylococcus, Pseudomonas
aeruginosa, Klebsiella spp, Enterobacter spp) are the pathogens that
cause most HAIs (79.1%),26,28 health care disinfectants should be ef-
fective against these pathogens.10
The other component, the practice, is thorough application such
that the disinfectant contacts all hand-contact or touchable sur-
faces. It also involves proper training of hospital staff (especially
environmental services and nursing) and adherence to the man-
ufacturer’s label instructions (except in the cases where an institution
may prepare a formal risk assessment to follow alternate contact
times such as ≥1 minute for vegetative bacteria). Other factors that
affect practice and performance include sufficient contact time, con-
centration, surface type, ease of use, organic soil and hard water,
porosity of the surface, compatibility of the disinfectant with the
wipe used, and sufficient cleaning time. The combination of product
and practice results in effective surface disinfection, including the
reduction of patient risk via microbial removal and inactivation and
improved patient outcomes.10
DISINFECTION USING LOW-LEVEL DISINFECTANTS
It has long been recommended in the United States that envi-
ronmental surfaces in patient rooms be cleaned and disinfected on
a regular basis (eg, daily, 3 times per week), when surfaces are visibly
soiled, and after patient discharge (terminal cleaning).29 There are
now data that demonstrate daily disinfection of high-touch sur-
faces (compared with cleaning when soiled) was associated with
a significant reduction in the frequency of pathogens on investi-
gators’ hands after contact with the surfaces and the mean number
of bacteria acquired.30 Disinfection is generally performed using an
EPA-registered hospital disinfectant, such as a quaternary ammo-
nium compound, chlorine, or phenol (Table 2). Newer products
effective against health care–associated pathogens include im-
proved hydrogen peroxide (HP) and peracetic acid–HP.11,31-33
MONITORING AND IMPROVING THE THOROUGHNESS OF
CLEANING-DISINFECTION
The cleaning-disinfection of noncritical surfaces in hospitals is
essential for reducing microbial contamination and reducing
HAIs.12,13,18 A recent Agency for Healthcare Research and Quality
review offers an overview of the monitoring modalities,12,13 which
include visual inspection, microbiologic methods, fluorescent
Table 1
Properties of an ideal disinfectant
Ideal properties
1. Broad spectrum: it should have a wide antimicrobial spectrum, including kill claims for the pathogens that are the common causes of HAIs and outbreaks.
2. Fast acting: it should have a rapid kill and short kill-contact time listed on the label.
3. Remains wet: it should keep surfaces wet long enough to meet listed kill-contact times with a single application or meet wet-times recommended by evidence-
based guidelines.
4. Not affected by environmental factors: it should be active in the presence of organic matter (eg, blood, sputum, feces) and compatible with cotton, microfiber,
soaps, detergents, and other chemicals encountered in use.
5. Nontoxic: it should not be irritating to the user, visitors, and patients. It should not induce allergic symptoms (especially asthma and dermatitis). The toxicity
ratings for disinfectants are danger, warning, caution, and none. Everything being equal, choose products with the lowest toxicity rating.
6. Surface compatibility: it should be proven compatible with common health care surfaces and equipment.
7. Persistence: it should have sustained antimicrobial activity or residual antimicrobial effect on the treated surface.
8. Easy to use: it should be available in multiple forms, such as wipes (large and small), sprays, pull-tops, and refills. Directions for use should be simple and contain
information about personal protective equipment as required.
9. Acceptable odor: it should have an odor deemed acceptable by users and patients or no odor.
10. Economical: costs should not be prohibitively high, but when considering costs of disinfectant should also consider product capabilities, cost per compliant use,
and so forth.
11. Solubility: it should be soluble in water.
12. Stability: it should be stable in concentrate and use dilution.
13. Cleaner: it should have good cleaning properties.
14. Nonflammable: it should have flash point >150°F.
NOTE. Modified with permission from Molinari et al17 and Rutala and Weber.10
Abbreviation: HAI, health care–associated infection.
markers, and adenosine triphosphate (ATP) assays. At present, poly-
merase chain reaction–based technology has a limited role for
assessing environmental contamination, is investigational, and does
not differentiate between the presence of viable and nonviable
microorganisms.13
Hospital cleanliness continues to attract patient attention, and
in the United States it is still primarily assessed via visual cleanli-
ness (eg, dust, organic debris) of surfaces, which is not a reliable
indicator of microbial contamination.34,35 ATP bioluminescence mea-
sures organic debris (each unit has its own reading scale, <250-
500 relative light units), but it is not a reliable indicator of microbial
contamination.13 A validation study of ATP used to audit cleaning
of flexible endoscope channels demonstrated that an endoscope as-
sessed as clean by ATP (<250 relative light units) could be
contaminated with a million (106) microorganisms.36 Fluorescent
marking is done with a transparent, easily cleaned, environmen-
tally stable marking solution that fluoresces when exposed to an
ultraviolet (UV) light. It is applied by the infection preventionist or
environmental service manager after the patient is discharged
and is unknown to the environmental service staff. After
Table 2
Summary of advantages and disadvantages of disinfectants used as low-level disinfectants
Disinfectant active Advantages Disadvantages




• Used to disinfect small surfaces, such as rubber stoppers
on medication vials
• No toxic residue
• Not sporicidal
• Affected by organic matter
• Slow acting against nonenveloped viruses (eg, norovirus)
• No detergent or cleaning properties
• Not EPA registered
• Damage to some instruments (eg, hardens rubber,
deteriorates glue)
• Flammable (large amounts require special storage)
• Evaporates rapidly, making contact time compliance
difficult
• Not recommended for use on large surfaces
• Outbreaks ascribed to contaminated alcohol24
Sodium hypochlorite • Bactericidal, tuberculocidal, fungicidal, virucidal
• Sporicidal
• Fast-acting
• Inexpensive (in dilutable form)
• Not flammable
• Unaffected by water hardness
• Reduces biofilms on surfaces
• Relatively stable (eg, 50% reduction in chlorine
concentration in 30 d)25
• Used as the disinfectant in water treatment
• EPA registered
• Reaction hazard with acids and ammonias
• Leaves salt residue
• Corrosive to metals (some ready-to-use products may be
formulated with corrosion inhibitors)
• Unstable active (some ready-to-use products may be
formulated with stabilizers to achieve longer shelf life)
• Affected by organic matter
• Discolors and stains fabrics
• Potential hazard is production of trihalomethane
• Odor (some ready-to-use products may be formulated
with odor inhibitors); irritating at high concentrations
Improved hydrogen
peroxide
• Bactericidal, tuberculocidal, fungicidal, virucidal
• Fast efficacy
• Easy compliance with wet-contact times
• Safe for workers (lowest EPA toxicity category, IV)





• More expensive than most other disinfecting actives
• Not sporicidal at low concentrations
Iodophors • Bactericidal, mycobactericidal, virucidal
• Not flammable
• Used for disinfecting blood culture bottles
• Not sporicidal
• Shown to degrade silicone catheters
• Requires prolonged contact to kill fungi
• Stains surfaces
• Used mainly as an antiseptic rather than disinfectant
Phenolics • Bactericidal, tuberculocidal, fungicidal, virucidal





• Absorbed by porous materials and irritate tissue
• Depigmentation of skin caused by certain phenolics









• Bactericidal, fungicidal, virucidal against enveloped viruses
(eg, HIV)
• Good cleaning agents
• EPA registered
• Surface compatible
• Persistent antimicrobial activity when undisturbed
• Inexpensive (in dilutable form)
• Not sporicidal
• In general, not tuberculocidal and virucidal against
nonenveloped viruses
• High water hardness and cotton-gauze can make less
microbicidal
• A few reports documented asthma as result of exposure to
benzalkonium chloride
• Affected by organic matter




• Bactericidal, fungicidal, virucidal and sporicidal (eg,
Clostridium difficile)
• Active in the presence of organic material
• Environmental friendly by-products (acetic acid, O2, H20)
• EPA registered
• Surface compatible
• Lack of stability
• Potential to material incompatibility (eg, brass, copper)
• More expensive than other disinfecting actives
• Odor
NOTE. Modified with permission from Rutala and Weber.10
Abbreviation: EPA, Environmental Protection Agency.
environmental service cleaning, the markings are reassessed by the
infection preventionist or environmental service manager, thor-
oughness of the cleaning is monitored, and immediate feedback is
provided to the person(s) cleaning-disinfecting the room (eg, 4 of
10 marker surfaces wiped, 40% compliance with thoroughness of
cleaning-disinfection). Microbiologic methods have also been used
to evaluate microbial contamination of surfaces. This method can
be costly and pathogenic specific. Although there are no accepted
criteria for defining a surface as clean using microbiologic methods,
some investigators have suggested that microbial contamination
should be 2.5 to <5 colony forming units (CFU)/cm2.37,38 Studies have
shown that this level of contamination may be easily achievable
because the microbial burden of room surfaces in 1 hospital went
from 57 CFU/Rodac (replicate organism detection and counting)
(2.3 CFU/cm2) to 8 CFU/Rodac (0.3 CFU/cm2) prior to and after
cleaning.39 Based on surface cleaning-disinfection practices that are
used in the United States, a revised stricter pass benchmark may
need to be considered (<1 CFU/cm2).
Studies have demonstrated suboptimal cleaning by aerobic colony
counts and the use of the ATP bioluminescence and fluorescent
markers.6,35 For example, Carling et al assessed the thoroughness
of terminal cleaning in the patient’s immediate environment in 23
acute care hospitals (1,119 patient rooms) by using a transparent,
stable solution that fluoresces when exposed to handheld UV light.40
The overall thoroughness of cleaning, expressed as a percent of sur-
faces evaluated, was 49% (range for all hospitals, 35%-81%). Using
a similar design, Carling et al assessed the environmental cleaning
in intensive care unit rooms in 16 hospitals (2,320 objects) and dem-
onstrated that only 57.1% of sites were cleaned after discharge of
the room’s occupant.41 A study using ATP bioluminescence assays
and aerobic cultures demonstrated that medical equipment fre-
quently had not been disinfected as per protocol.42
ATP bioluminescence and fluorescent markers are preferred to
aerobic plate counts because they provide an immediate assess-
ment of cleaning effectiveness. Two recent reviews reported ATP as
a quick and objective monitoring method; however, it was poorly
standardized with low specificity and sensitivity in detecting
bacteria.13,43,44 In a comparison study of the 4 methods to assess
cleaning, we found that the fluorescent marker was the most useful
tool in determining how thoroughly a surface was wiped because
it mimicked the microbiologic data better than ATP. For example,
compared with microbiologic data (when <62.5 CFU/Rodac defines
clean), 72% were classified as clean with fluorescent markers, com-
pared with 27% were classified as clean compared with ATP (Rutala
et al, unpublished results, 2015).
SURFACE DISINFECTION, CONTACT TIME, WIPES AND
WIPE METHOD
Surface disinfection of noncritical surfaces and equipment is nor-
mally performed by manually applying a liquid disinfectant to the
surface with a wipe or mop. Noncritical patient care equipment is
disinfected using an EPA-registered hospital disinfectant using the
label’s safety precautions and use directions (Table 2). Many diluted
EPA-registered hospital disinfectants have a label contact time of
10 minutes (eg, quaternary ammonium compound). However, mul-
tiple scientific studies have demonstrated the efficacy of hospital
disinfectants against pathogens with a contact time of at least 1
minute.10,29 Health care facilities should ensure that the frequency
for disinfecting noncritical patient care surfaces be done minimal-
ly when visibly soiled and on a regular basis (eg, after use on each
patient or once daily or once weekly).29 Data indicate that daily dis-
infection of high-touch surfaces, compared with disinfecting when
soiled, reduces the acquisition of pathogens on hands after contact
with surfaces and the mean number of bacteria acquired.30 For
example, a hospital’s policy for reusable blood pressure cuffs kept
in the patient room could be that they are cleaned when visibly
soiled and at discharge before use for another patient. Similarly, for
rolling blood pressure cuffs, the policy could be they are cleaned
daily and when visibly soiled, when used on a contact precaution
patient, and when used on nonintact skin. If dedicated, disposable
equipment is not available, disinfect noncritical patient care equip-
ment after using it on a patient who is on contact precautions before
using this equipment on another patient.
The wipes used for surface disinfection are generally cotton,
cellulose-based, nonwoven spunlace, and microfiber. The disinfec-
tants are usually appliedwith a spray (ie, spray-and-wipe procedure),
wipes (eg, cotton, microfiber) soaked in a disinfectant-filled bucket,
or a premoistened wipe (eg, disposable wipe). All of these methods
combine the antimicrobial action of the disinfectant with the phys-
ical removal of microorganisms by wiping. The efficacy of the wipe
method has been recently evaluated using C difficile spores. The wipe
methods (ie, saturated cloth; spray [let disinfectant sit for 10 seconds]
and wipe; spray, wipe, spray [let disinfectant sit for 1 minute], and
wipe; disposable wipe; spray, wipe, spray, and let air dry) all dem-
onstrated similar reductions in C difficile spores using a disinfectant
active against C difficile spores.22 The wipe should have sufficient
wetness to achieve the disinfectant contact time. Discard the wipe
if it no longer leaves the surface visibly wet for ≥1 minute. Other
practices to consider include the following: when the wipe is visibly
soiled, flip to a clean-unused side and continue until all sides of the
wipe have been used (or get another wipe); dispose of the wipe or
cloth wipe appropriately; do not place the cleaning cloth back into
the disinfectant solution after using it to wipe a surface; and do not
dip a used wipe into the clean container of presaturated wipes. If
a disposable wipe is used, ideally the wipe should keep the surface
wet long enough to meet EPA-registered contact times (eg, bacte-
ria: 1 minute). For disposable wipes, the premoistened wipe should
keep the surface area wet for 1-2 minutes, and the surface cover-
age will depend on the size of the wipe (eg, 12- × 12-in wipes keep
5.156 sq m wet for 2 minutes; 6- × 5-in equipment wipe keeps
0.622 sq m wet for 2 minutes). The disposable wipe size should be
based on use from small surfaces (eg, blood pressure cuff) to large
Table 3
Most prevalent pathogens causing HAIs























Most common causes of
outbreaks and ward closures
by causative pathogen, which
are relatively hard to kill27
(Insert facility-specific pathogens here
[eg, Burkholderia cepacia])
Other pathogens of concern in
your facility
NOTE. Modified from Rutala and Weber.10
Abbreviations: CDC, Centers for Disease Control and Prevention; HAI, health care–
associated infection; NHSN, National Healthcare Safety Network.
*Over the last decade, an increasing incidence of C difficile has been recognized, and
in many health care facilities it is the most common cause of HAI.
surfaces (eg, mattress covers). Additionally, the substrate for the dis-
posable wipe should be durable so that it does not easily tear or
fall apart, and the top should be kept closed so the wipes do not
dry out. Change the reusable cleaning cloths after every room and
use at least 3 cloths per room.10,45 Boyce et al also found that smooth
surfaces (eg, overbed tables) were cleanedmore thoroughly (as mea-
sured by ATP) than rough or irregular surfaces, and the rooms
cleaned with only 2 disinfectant wipes had higher ATP readings than
those cleaned with 3, 4, or 5 wipes.46 If the reusable wipe is not
changed, accumulation of bacteria can occur and increase the chance
of cross-contamination.
In addition, the antimicrobial activity of some disinfectants will
be affected by certain fabrics or cloths. Quaternary ammonium com-
pounds interact with cotton and microfiber cloths via electrostatic
attractions, resulting in lower concentrations of the active ingre-
dient delivered to the surface. For example, cotton rags or disposable
cellulose-based wipes with quaternary ammonium compoundsmay
release lower amounts of active quaternary ammonium com-
pounds (≥30% lower) than nonwoven spunlace wipes than is
indicated by testing the solution.47 Engelbrecht et al found that the
quaternary ammonium compound concentration was reduced by
up to 85% after exposure to cotton towels.48 Even though cotton and
microfiber retain the quaternary ammonium compound, 1 study has
shown they provide equivalent removal-inactivation of MRSA from
a surface as nonwoven spunlace wipes (eg, 4.41 log10 reduction with
cotton and QUAT (a quaternary ammonium compound), 4.60 log10
reduction with spunlace, 4.51 log10 reduction with microfiber, 4.40
log10 reductionwith cellulose; Rutala et al, unpublished results, 2013).
Additional investigations are necessary to ensure a minimum ef-
fective concentration is present to achieve the antimicrobial label
claim.
An issue that has been receiving repeated attention in the media
is the contact times for disposable wipes when there are varying
times listed for bacteria, fungi, andmycobacteria. Some persons have
suggested that hospitals should use the longest kill time on the
product as the required wet-contact kill time (eg, 5 minutes forMy-
cobacterium bovis). The CDC’s “Guideline for Disinfection and
Sterilization in Healthcare Facilities” used the time necessary to kill
bacteria on surfaces (ie, 1 minute), not the kill time for more dif-
ficult to inactivate pathogens, such asM tuberculosis orMbovis, which
does not have an environmental surface mode of transmission.29
Because bacteria (with the exception of C difficile spores) to include
multidrug-resistant bacteria (eg, MRSA, VRE) cause approximate-
ly 80% of HAIs and removal or inactivation of bacteria on surfaces
is important in preventing environmentally mediated HAIs, bacte-
rial kill times should dictate the wet-contact kill times in health care
facilities. Therefore, for low-level disinfectant products used on non-
critical environmental surfaces or noncritical medical instruments,
the recommended wet-contact kill times would be ≥1 minute.
IMPROVING ROOM CLEANING AND DISINFECTION AND
DEMONSTRATING THE EFFECTIVENESS OF SURFACE
DECONTAMINATION IN REDUCING HAIS
Investigators have reported that intervention programs aimed
at improving surface cleaning and disinfection reduced HAIs.18 Such
interventions have generally included multiple activities: disinfec-
tant product substitutions and interventions to improve the
effectiveness of cleaning and disinfection (eg, improved housekeep-
er education, monitoring the thoroughness of cleaning [eg, by use
of ATP assays or fluorescent dyes] with feedback of perfor-
mance to the environmental service workers, use of cleaning
checklists).18,49-51 Health care facilities must also allow adequate time
for room processing to ensure adherence to all steps recom-
mended by institutional policies and professional organization
guidelines. We have found that collaboration between infection pre-
vention and environmental services staff andmanagement is critical
to an effective environmental cleaning program. This includes en-
suring that environmental services staff recognize the importance
of their job and the relationship of adhering to proper work pro-
cedures to the reduction of microbial contamination and HAIs. The
assignment of cleaning responsibility (eg, medical equipment to be
cleaned by nursing; environmental surfaces to be cleaned by en-
vironmental services) is also important to ensure all objects and
surfaces in a patient room are decontaminated, especially the sur-
faces of medical equipment (eg, cardiac monitors). Improved
environmental cleaning has been demonstrated to reduce the en-
vironmental contamination with VRE,51 MRSA,52 and C difficile.53
Further, all studies have only focused improvement on a limited
number of high-risk objects. Therefore, a concern of published
studies is that they have only demonstrated improved cleaning of
a limited number of high-risk objects (or targeted objects), not an
improvement in the overall thoroughness of room decontamina-
tion, which is the objective.
To our knowledge only 1 study has objectively evaluated what
constitutes high-touch objects in a patient room, and no study has
demonstrated epidemiologically what constitutes a high-risk object.
Examples of what the literature refers to as high-touch objects
include bed rails, intravenous poles, call buttons, door knobs, floors,
and bathroom facilities,13 but a study demonstrated high-touch
objects in the intensive care unit were the bed rail, bed surface, and
supply cart, whereas the high-touch surfaces in a patient ward were
the bed rail, over-the-bed table, intravenous pump, and bed surface.54
Importantly, the level of microbial contamination of room sur-
faces was statistically similar regardless of how often they were
touched before and after cleaning. Until research identifies which
objects and surfaces pose the greatest risk of pathogen trans-
mission, all noncritical surfaces that are touched must be
cleaned-disinfected.39
NO-TOUCH (OR MECHANICAL) METHODS FOR
ROOM DECONTAMINATION
As previously noted, multiple studies have demonstrated that
environmental surfaces andobjects in rooms are frequently not prop-
erly cleaned, and these surfaces may be important in transmission
of health care–associated pathogens. Further, although interven-
tions aimed at improving cleaning thoroughness have demonstrated
effectiveness,many surfaces remain inadequately cleaned and there-
fore potentially contaminated. For this reason, severalmanufacturers
have developed roomdisinfection units that can decontaminate en-
vironmental surfaces and objects. These no-touch systems generally
use 1 of 2 methods: UV light or HP vapor-mist.4 These technologies
supplement, but do not replace, standard cleaning and disinfection
because surfaces must be physically cleaned of dirt and debris.
UV light for room decontamination
UV radiation has been used for the control of pathogenic mi-
croorganisms in a variety of applications, such as control of
legionellosis, and the disinfection of air, surfaces, and instruments.4,55
At certain wavelengths, UV light will break the molecular bonds in
DNA, thereby destroying the organism. UV radiation has peak ger-
micidal effectiveness in the wavelength range of 240-280 nm.
Mercury gas bulbs emit UV-C at 254 nm, whereas xenon gas bulbs
produce a broad spectrum of radiation that encompasses the UV
(100-280 nm) and the visible (380-700 nm) electromagnetic
spectra.56 The efficacy of UV radiation is a function of many differ-
ent parameters, such as dose, distance, direct or shaded exposure,
exposure time, lamp placement, pathogen, carrier or surface tested,
inoculummethod, organic load, and orientation of carriers (eg, par-
allel vs perpendicular). Data demonstrate that several UV systems
have effectiveness (eg, eliminate >3 log10 vegetative bacteria [MRSA,
VRE, A baumannii] and >2.4 log10 C difficile) at relatively short ex-
posure times (eg, 5-25 minutes for bacteria, 10-60 minutes for C
difficile spores).56-58 The studies also demonstrated reduced effec-
tiveness when surfaces were not in direct line of sight.56-60
HP systems for room decontamination
Several systems which produce HP (eg, HP vapor, aerosolized dry
mist HP) have been studied for their ability to decontaminate en-
vironmental surfaces and objects in hospital rooms. HP vapor has
been used increasingly for the decontamination of rooms in health
care.61-71 These investigators found that HP systems are a highly ef-
fective method for eradicating various pathogens (eg, MRSA, M
tuberculosis, Serratia, C difficile spores, C botulinum spores) from
rooms, furniture, and equipment.
Comparison of UV irradiation vs HP for room decontamination
The UV and HP systems have their own advantages and
disadvantages,4 and there is now ample evidence that these no-
touch systems can reduce environmental contamination with health
care–associated pathogens. However, each specific system should
be studied and its efficacy demonstrated before being introduced
into health care facilities. The main advantage of both types of units
is their ability to achieve substantial reductions in vegetative bac-
teria. Another advantage is their ability to substantially reduce C
difficile spores because low-level disinfectants (eg, quaternary am-
monium compounds) have only limited or no measurable activity
against spore-forming bacteria.10 Both systems are residual free, and
they decontaminate all exposed surfaces and equipment in the room.
The major disadvantages of both decontamination systems are
the substantial capital equipment costs, the need to remove per-
sonnel and patients from the room therefore limiting their use to
terminal room disinfection (must prevent or minimize exposure to
UV and HP), the staff time needed to transport the system to rooms
to be decontaminated and monitor its use, the need to physically
clean the room of dust and debris, and the sensitivity to use pa-
rameters. There are several important differences between the 2
systems. The UV-C systems offer faster decontamination, which
reduces the down time of the room before another patient can be
admitted. The HP systems have been demonstrated to be more ef-
fective in eliminating spore-forming organisms. Whether this
improved sporicidal activity is clinically important is unclear because
studies have demonstrated that although environmental contam-
ination is common in the rooms of patients with C difficile infection,
the level of contamination is relatively low (also true for MRSA and
VRE). Importantly, the HP and UV systems were demonstrated to
reduce the incidence of HAIs.61,72-75 Based on data that demon-
strated a reduction of colonizations and infections associated with
these technologies, we recommend they be used for terminal room
decontamination after discharge of patients on contact precau-
tions. Because different UV and HP systems vary substantially,
infection preventionists should review the peer-reviewed litera-
ture and choose only devices with demonstrated bactericidal
capability as assessed by carrier tests or the ability to disinfect actual
patient rooms. Ultimately, one would select a device that has dem-
onstrated the ability to reduce HAIs.75
FUTURE DIRECTIONS FOR NO-TOUCH TECHNOLOGIES
Novel technologies have dramatically improved the likelihood
of developing a self-disinfecting surface or a continuous room dis-
infection strategy. These strategies include the development of self-
disinfecting surfaces, such as surfaces impregnated or coated with
a heavy metal (eg, silver, copper) or a germicide (eg, quaternary am-
monium compounds).76-78 The use of such technology couldminimize
the impact of poor cleaning and disinfecting practices during routine
and terminal room cleaning and disinfection. Other novel methods
for room disinfection are being investigated. For example, visible
light disinfection through light-emitting diodes can be applied con-
tinuously to environments to provide microbial reductions even
while the environments are occupied. The light-emitting diodes
release a wavelength of light that is antimicrobial (405 nm) and not
hazardous to patients and staff.79 Another potential method for con-
tinuous room decontamination uses continuous low-dose HP (eg,
0.5 ppm HP vapor).
CONCLUSION
Environmental contamination plays an important role in the
transmission of several epidemiologically important pathogens, such
as MRSA, VRE, and C difficile. Disinfection should render surfaces
and equipment free of pathogens in sufficient numbers to cause
human disease (ie, hygienically clean). This requires thorough
cleaning-disinfecting of the patient environment using effective prod-
ucts and processes and no-touch technologies that reduce the
incidence of HAIs.
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